BOTALYS
PrivateLast Round
Series B
Oct 4, 2022
Total Funding Raised
$11.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BOTALYS is a biotechnology company that produces potent and pure botanical ingredients for the nutraceutical and cosmetic industries using a proprietary vertical farming technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Fashion & Beauty, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BOTALYS Comps
Public and private peers based on sector, stage, and business model.
BOTALYS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 4, 2022 | ||||
| Grant | May 31, 2021 | ||||
| Grant | Mar 1, 2019 | ||||
| VC Round | Jan 9, 2019 |
Key People
Founding team and executive leadership
BOTALYS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizon 2020 | Grant |
| Société Régionale d'Investissement de Wallonie | Series B |
| Air Liquide Venture Capital | Series B |
| VIVES Partners | VC Round |
| Wapinvest | Series B, Seed |
| European Union | Grant |
| The Yield Lab | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Added L’Oréal Group, a beauty & personal care company, as a customer.
- Jan 22, 2026
Added Thorne Research Inc. in Health & Wellness
BOTALYS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BOTALYS's valuation, stock price, and market status.